Argenx to Present at Investor Conferences
Argenx, a biotechnology company, will participate in upcoming investor conferences. The company’s stock, listed as ARGX, has experienced fluctuations in the past year.
Recent Stock Performance
The 52-week high for Argenx’s stock was 658 EUR on January 13, 2025. The 52-week low was 456.3 EUR on September 23, 2024. As of the last available data, the stock closed at 604 EUR.
Valuation Metrics
Argenx’s valuation metrics include:
- Price-to-earnings ratio: 36.59
- Price-to-book ratio: 7.1